ESMO Biosimilars Portal

Biosimilars Banner

Welcome to the ESMO Biosimilars Portal: Education, Resources for Patients, Awareness, Other Links

Welcome to the ESMO Biosimilars Portal

Education

ESMO Position Paper on Biosimilars - the position paper aims to describe the issues revolving around biosimilars that are relevant to the field of oncology, especially the prescribers

Resources for Patients

Awareness

Are Biosimilars the Key to Access, in Practice? – colloquium during ESMO 2018 to discuss about the use of oncology biosimilars and existing challenges

Oncology Biosimilars in Asia – colloquium during ESMO Asia 2017 focusing on the challenges and opportunities of oncology biosimilars in Asia

ESMO 2017 session on the Incoming Wave of Biosimilars in Oncology & event report Preparing for the Incoming Wave of Oncology Biosimilars – with the imminent arrival of oncology biosimilars, key stakeholders provide their perspective on optimising the uptake of these new agents

ESMO Asia 2017 colloquium on the Incoming Wave of Oncology Biosimilars, in Asia  – with the imminent arrival of oncology biosimilars, key stakeholders provide their perspective on optimising the uptake of these new agents in Asia

Other Relevant Links

  • EMA page on biosimilar medicines – gives an overview of biosimilars and the agency’s work in this area
  • EC/EMA Information guide for healthcare professionals: Biosimilars in the EU - provides reference information on the science and regulation underpinning the use of biosimilar medicines (produced with input from clinical experts including ESMO)
  • European Commission multi-stakeholder workshop on biosimilars – annual meeting to promote the exchange of knowledge and best practices in biosimilars' use and uptake (ESMO chaired sessions in 2017 and 2018)

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings